Clinical Trials Browser

Phase 2 × Osteosarcoma × Eflornithine × Clear all

NCT07321912 2026-05-26

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma